Analysis of Id1 expression in a 237 AML patient cohort demonstrated that AML patients with high levels of ID1 gene expression were less likely to achieve complete remission and were correlated with shorter disease-free survival and overall survival (113). The gene discussed is ID1; the disease is acute myeloid leukemia.